VIRCO MFG CORPORATION
VIRCOther · Accelerated filer<br>Smaller reporting company · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | |
|---|---|---|---|---|---|---|
| Revenue | $199.7M | $266.2M | $269.1M | $231.1M | $184.8M | $152.8M |
| Operating income | $3.7M | $27.9M | $31.9M | $10.6M | −$336,000 | $735,000 |
| Net income | $2.6M | $21.6M | $21.9M | $16.5M | −$15.1M | −$2.2M |
| Total assets | $174.2M | $191.9M | $146.4M | $150.1M | $126.4M | $125.0M |
| Total liabilities | — | — | — | — | — | — |
| Equity | $105.9M | $109.3M | $91.2M | $68.1M | $47.4M | $54.2M |
| EPS (diluted) | $0.16 | $1.32 | $1.34 | $1.02 | $-0.95 | $-0.14 |
| Shares out. | 15.8M | 16.1M | 16.3M | 16.2M | 16.1M | 15.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2026- Operating margin
- 1.8%
- Net margin
- 1.3%
- Return on equity
- 2.4%
- Return on assets
- 1.5%
- Return on capital (ROCE)
- 2.6%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $6.72
- Revenue growth (YoY)
- −25.0%
- Net income growth (YoY)
- −88.1%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2026- Accruals / assets
- 2.0%clean
- Piotroski F-Score
- 3/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 warning● 2 good- Revenue declined year-over-year
- Negative operating cash flow
- Operating margin is positive
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Virtue Douglas APassive (13G)Feb 17, 2026
- Minerva Advisors LlcPassive (13G)Feb 17, 2026
- Cleveland Capital Management, L.L.C.Passive (13G)Feb 2, 2026
- Dimensional Fund Advisors LpPassive (13G)Jan 21, 2026
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Virtue Douglas AOfficer — Executive Vice President | Apr 14, 2026 | Buy | 4,349 | $6.07 |
| Lind Robert RDirector | Apr 15, 2026 | Buy | 500 | $6.07 |
| Virtue Robert AOfficer — CEO | Apr 14, 2026 | Buy | 700 | $6.22 |
| Richardson Bradley CDirector | Apr 10, 2026 | Buy | 1,600 | $5.59 |
| Virtue Robert AOfficer — CEO | Apr 10, 2026 | Buy | 3,300 | $5.52 |
| Virtue Robert AOfficer — CEO | Jan 13, 2026 | Buy | 2,500 | $6.32 |
| Richardson Bradley CDirector | Jan 7, 2026 | Buy | 2,000 | $6.50 |
| Virtue Douglas AOfficer — Executive Vice President | Oct 17, 2025 | Buy | 13,022 | $7.34 |
| Virtue Robert AOfficer — CEO | Oct 16, 2025 | Buy | 5,000 | $6.96 |
| Virtue Robert AOfficer — CEO | Jul 14, 2025 | Buy | 2,000 | $8.15 |
| Levra Craig LDirector | Jun 17, 2025 | Grant | 4,601 | $8.14 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 558,726 | 16.7 | -0.9% |
| Apr 30, 2026 | 563,819 | 13.2 | +1.9% |
| Apr 15, 2026 | 553,533 | 12.4 | +0.4% |
| Mar 31, 2026 | 551,247 | 16.6 | +2.6% |
| Mar 13, 2026 | 537,171 | 13.4 | +5.2% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsApr 8, 2026
- Regulation FD disclosureMar 9, 2026
- Results of operations · Regulation FD disclosureDec 8, 2025
- Results of operations · Regulation FD disclosureSep 5, 2025
- Director / officer change · Shareholder voteJun 20, 2025
- Results of operations · Changed auditor · Regulation FD disclosureJun 6, 2025
- Results of operationsApr 14, 2025
- Director / officer change · Regulation FD disclosureMar 12, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- ARSMay 4, 2026
- DEF 14AMay 4, 2026
- 4FORM 4Apr 15, 2026
- 4FORM 4Apr 15, 2026
- 4FORM 4Apr 14, 2026
- 4FORM 4Apr 13, 2026
- 4FORM 4Apr 13, 2026
- 10-KApr 8, 2026
- 8-KApr 8, 2026
- 8-KMar 9, 2026
- SCHEDULE 13G/AFeb 17, 2026
- SCHEDULE 13G/AFeb 17, 2026
- SCHEDULE 13GFeb 2, 2026
- SCHEDULE 13G/AJan 21, 2026
- 4FORM 4Jan 13, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.